Videos

Featured

AHA 22: 4 Trials That Will Change Your Practice With Interventionalist, Dr Alasnag

Mirvat Alasnag,

Watch time: 12m 38s
AHA 22: NOVA: Botulinium Toxin Type A in Patients with Post-Operative Atrial Fibrillation

Jonathan Piccini,

Watch time: 9m 16s
Radcliffe & CardioNerds @AHA22: The ECMO-CS Trial

Petr Ostadal, Saahil A Jumkhawala,

Watch time: 13m 45s
Radcliffe & CardioNerds @AHA22: PROGRESSIVE-AF: Impact of “First-Line” Rhythm Therapy on Afib Progression

Jason G Andrade, Kate Wilcox,

Watch time: 13m 6s

Paul Wang,

Watch time: 8m 16s

Joost Daemen, Nicolas M Van Mieghem,

Watch time: 30m
View from the Thoraxcenter: AHA 22 Late-breaking Science Wrap-up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 35m 25s
AHA 22: Late-Breaker Discussion: The STRONG-HF Trial

Alexandre Mebazaa, Harriette Van Spall,

Watch time: 21m 14s
Radcliffe & CardioNerds @AHA22: Reduction of Lp(a) With Small Interfering RNA

Gurleen Kaur, Michelle O'Donoghue,

Watch time: 14m 29s
Radcliffe & CardioNerds @AHA22: Reduction of Triglycerides With Pemafibrate

Aruna D Pradhan, Gurleen Kaur,

Watch time: 14m 25s

Trending

Diana Gorog, Sotiris Antoniou , Franco Cheng, et al

AHA 22: Late-Breaker Discussion: The STRONG-HF Trial

Alexandre Mebazaa, Harriette Van Spall,

Watch time: 21m 14s

Joseph A Hill, Mirvat Alasnag,

AHA 22: 4 Trials That Will Change Your Practice With Interventionalist, Dr Alasnag

Mirvat Alasnag,

Watch time: 12m 38s
AHA 22: Results of the CRISPR-Cas9 First-in-Human Trial

Julian Gillmore,

Watch time: 8m 12s

Justin Ezekowitz, Harriette Van Spall, Dylan L Steen, et al

AHA 22 Late-Breaking Science Highlights With Dr Joseph Hill

Joseph A Hill,

Watch time: 5m 4s
AHA 22: NOVA: Botulinium Toxin Type A in Patients with Post-Operative Atrial Fibrillation

Jonathan Piccini,

Watch time: 9m 16s
Radcliffe & CardioNerds @AHA22: PROGRESSIVE-AF: Impact of “First-Line” Rhythm Therapy on Afib Progression

Jason G Andrade, Kate Wilcox,

Watch time: 13m 6s
AHA 22: RESPECT EPA: Eicosapentaenoic Acid for Prevention of Coronary Artery Disease

Hiroyuki Daida, Saahil A Jumkhawala,

Watch time: 14m 14s

Events

Filter by

AHA 22: 4 Trials That Will Change Your Practice With Interventionalist, Dr Alasnag

Mirvat Alasnag,

Watch time: 12m 38s
AHA 22: SPYRAL HTN-ON MED: Renal Denervation in Patients with Hypertension

David Kandzari,

Watch time: 10m 6s
AHA 22 Late-Breaking Science Highlights With Dr Joseph Hill

Joseph A Hill,

Watch time: 5m 4s
AHA 22: NOVA: Botulinium Toxin Type A in Patients with Post-Operative Atrial Fibrillation

Jonathan Piccini,

Watch time: 9m 16s
Radcliffe & CardioNerds @AHA22: The ECMO-CS Trial

Petr Ostadal, Saahil A Jumkhawala,

Watch time: 13m 45s
Radcliffe & CardioNerds @AHA22: PROGRESSIVE-AF: Impact of “First-Line” Rhythm Therapy on Afib Progression

Jason G Andrade, Kate Wilcox,

Watch time: 13m 6s
AHA 22: RESPECT EPA: Eicosapentaenoic Acid for Prevention of Coronary Artery Disease

Hiroyuki Daida, Saahil A Jumkhawala,

Watch time: 14m 14s

Paul Wang,

Watch time: 8m 16s
View from the Thoraxcenter: AHA 22 Late-breaking Science Wrap-up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 35m 25s
AHA 22: Late-Breaker Discussion: The STRONG-HF Trial

Alexandre Mebazaa, Harriette Van Spall,

Watch time: 21m 14s

Latest

Filter by

AHA 22: 4 Trials That Will Change Your Practice With Interventionalist, Dr Alasnag

Mirvat Alasnag,

Watch time: 12m 38s
AHA 22: SPYRAL HTN-ON MED: Renal Denervation in Patients with Hypertension

David Kandzari,

Watch time: 10m 6s
AHA 22 Late-Breaking Science Highlights With Dr Joseph Hill

Joseph A Hill,

Watch time: 5m 4s
AHA 22: NOVA: Botulinium Toxin Type A in Patients with Post-Operative Atrial Fibrillation

Jonathan Piccini,

Watch time: 9m 16s
Radcliffe & CardioNerds @AHA22: The ECMO-CS Trial

Petr Ostadal, Saahil A Jumkhawala,

Watch time: 13m 45s
Radcliffe & CardioNerds @AHA22: PROGRESSIVE-AF: Impact of “First-Line” Rhythm Therapy on Afib Progression

Jason G Andrade, Kate Wilcox,

Watch time: 13m 6s
AHA 22: RESPECT EPA: Eicosapentaenoic Acid for Prevention of Coronary Artery Disease

Hiroyuki Daida, Saahil A Jumkhawala,

Watch time: 14m 14s

Paul Wang,

Watch time: 8m 16s